Re: GeneXpert machine and Xpert MTB/RIF cartridge pricing, extended warranties and business in Russia and the People’s Republic of China

CHMP has recommended granting a conditional marketing authorisation for Sirturo (bedaquiline).

Multidrug-resistant tuberculosis remains a major public health concern in several countries in the region, including in the European Union.

Leading doctors, advocacy groups, medical organizations and U.S. TB programs commend Sanofi U.S. commitment to reduce the price of tuberculosis drug rifapentine.

Corruption, staged competition, abuse of commercial secrets, and speculations over the official status prevent Ukraine from overcoming the epidemics of HIV/AIDS and TB, both of which have threatened the country’s national security.

The purpose of the report is to highlight developments that have occurred since July 2013 – namely, in the areas of policy development, implementation and scale-up of the Xpert® MTB/RIF assay and efforts to define the characteristics of next-generation molecular tests that could replace smear microscopy.

New approaches to paediatric TB care should be integrated into every TB project and National TB programme.

ECDC promotes and encourages EU/EAA countries to raise the profile of childhood TB in national childhood TB prevention and control strategies and guidelines.

Sanofi U.S. has committed to lowering the price of rifapentine (Priftin) to $32 per 32-tablet blister pack in January 2014.

Childhood TB has been neglected for decades, but in the past few years the WHO has begun to realise its real impact in terms of incidence, prevalence and mortality.